SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-023198
Filing Date
2019-06-24
Accepted
2019-06-24 08:00:27
Documents
2
Period of Report
2019-06-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K odt-8k_20190620.htm 8-K 29295
2 EX-3.1 odt-ex31_24.htm EX-3.1 87014
  Complete submission text file 0001564590-19-023198.txt   117681
Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38318 | Film No.: 19913334
SIC: 2834 Pharmaceutical Preparations